scott@vtx-cpd.com
Forum Replies Created
-
AuthorPosts
-
Hello Liz and everyone,
Thank you for the warm welcome! And thank you to everyone for joining the course.
A little about myself: I’m one of the other directors of VTX and a specialist in small animal internal medicine. While I’m no good at cardiology, I’m happy to answer any medicine questions you might have!
I’m looking forward to the journal club in July and to engaging with everyone on the forum. It will be great to exchange knowledge and experiences.
Best wishes,
Scott
Replying to Jon H. 14/05/2024 - 15:00
Hi Jon,
Welcome to the group! We’re really honoured to have you with us and look forward to learning from your expertise.
Scott π
Replying to Suzi Bailey 15/05/2024 - 18:00
Hi Suzi,
It sounds like you’re in a challenging situation with your cat. Osteonecrosis is indeed a known side effect of long-term bisphosphonate use, including alendronate. While your cat has been stable on alendronate with resolved mild azotemia, the potential risks of long-term use should be carefully considered.
If the cat is stable and responding well to the current treatment, it might be prudent to continue monitoring closely and discussing the potential risks and benefits with the owner.
This is a tricky one! It is never a side effect that I have witnessed in real life (knowingly) but feline specialists such as Danielle Gunn-Moore and Stephanie Sorrell are moving away from using it for this reason. If the cat is doing well and tabling is difficult, I would not be rushing to change.
Would it be an option to try diet and chia seeds in this case and see if you could transition off?
You may find this reference helpful: Link to the PubMed article.
Best regards,
Scott
Replying to Helen D. 08/05/2024 - 07:23
Hey Helen.
Thank you for your brilliant question. I hope you are enjoying the course!
The caution around using metoclopramide in cases of gastrointestinal hemorrhage is primarily due to its mechanism of action, which involves enhancing gastrointestinal motility. In the context of active hemorrhage, increased motility could potentially worsen bleeding or interfere with the formation of clots at the site of hemorrhage.
However, it’s important to note that metoclopramide can be a valuable tool in managing gastrointestinal conditions, including cases of ileus. In situations where the benefits of using metoclopramide outweigh the risks, such as in cases of ileus associated with haemorrhagic gastroenteritis (HGE), its use may be justified. I am personally very comfortable using metoclopramide in these cases, as managing the ileus is almost certainly more important than avoiding the drug due to the risk of gastrointestinal haemorrhage.
I hope that helps!
Scott π
Replying to Hannah Willetts 04/05/2024 - 17:43
Hello again!
There was actually a recent paper looking at this:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800230/pdf/JVIM-38-228.pdf
This study aimed to identify risk factors for thrombotic disease (TD) in dogs with renal proteinuria, focusing on systemic arterial (AT), systemic venous (VT), and pulmonary circulation (PT) thrombosis. They analyzed data from 150 dogs with renal proteinuria, 50 of which had TD. They found that Cavalier King Charles Spaniels were more likely to have TD. Dogs with TD had higher neutrophil counts and lower eosinophil counts in their blood, as well as lower serum albumin levels compared to those without TD. Additionally, dogs with AT had higher serum albumin levels than those with VT, and they were older than dogs with PT. Dogs with VT were older and had higher serum cholesterol levels compared to those with PT. These findings suggest that differences in thrombus locations may indicate differences in the underlying causes of thrombosis.
Scott π
Replying to Hannah Willetts 04/05/2024 - 17:43
Hello Hannah.
Thank you for your brilliant question. I really hope you are enjoying the course.
In cases of protein-losing nephropathy (PLN), the loss of proteins, including albumin, through the kidneys can contribute to a hypercoagulable state through several mechanisms:
1. Decreased Anticoagulant Proteins: The loss of proteins via the kidneys can include anticoagulant proteins such as antithrombin III and protein C. These proteins normally help regulate the coagulation process by inhibiting clot formation. Their loss can tip the balance towards a pro-coagulant state.
2. Increased Fibrinogen Levels: PLN can lead to increased levels of fibrinogen, a key protein involved in the clotting cascade. Elevated fibrinogen levels can promote clot formation.
3. Altered Platelet Function: PLN can affect platelet function, making them more prone to aggregation and clot formation.
4. Endothelial Dysfunction: Protein loss and associated kidney damage can lead to endothelial dysfunction, which can further promote clot formation.
5. Haemoconcentration: Similar to other conditions causing protein loss, PLN can lead to hemoconcentration, increasing the concentration of clotting factors in the blood.
Overall, the combination of these factors in PLN can contribute to a hypercoagulable state, increasing the risk of thrombosis.
More specifically regarding the albumin part of your question:
Albumin loss can lead to a hypercoagulable state due to several factors. Albumin plays a crucial role in maintaining the balance of oncotic pressure in the blood, which helps prevent fluid from leaking out of the blood vessels into the surrounding tissues. When albumin is lost, there is a decrease in oncotic pressure, leading to increased fluid leakage. This can result in haemoconcentration, where the concentration of cells and proteins in the blood increases, including clotting factors, which can contribute to a hypercoagulable state.
Additionally, albumin is involved in the regulation of fibrinolysis, the process that dissolves clots. A decrease in albumin levels can lead to impaired fibrinolysis, further promoting a pro-coagulant state.
Regarding your second question, there isn’t a specific threshold of albumin loss below which anticoagulants are always indicated. The decision to use anticoagulants would depend on the overall clinical picture, including the presence of other risk factors for thrombosis, such as immobility, underlying diseases, and the specific condition of the patient. In cases where there is significant albumin loss and evidence of a hypercoagulable state, anticoagulants may be considered, but this decision would be made on a case-by-case basis. I would generally consider anticoagulants/antithrombotic when albumin is below 15g/l.
I hope this helps clarify things for you! Let me know if you have any more questions.
Scott π
Replying to Kristin Herstad 03/05/2024 - 14:49
In summary!
The case involves a cat with angioinvasive pulmonary carcinoma with presumed metastasis to the posterior segment. Pulmonary adenocarcinoma, the likely cancer type, is not typically responsive to chemotherapy in cats. Limited literature exists on chemotherapy for primary pulmonary carcinoma without metastasis. The prognosis for feline lower airway disease with this cancer is very poor.
https://pubmed.ncbi.nlm.nih.gov/11397254/
Scott π
Replying to Kristin Herstad 03/05/2024 - 14:49
Kristin,
Thank you so much for your brilliant comments and suggestions. It is important to note that no obvious orthopaedic abnormalities were noted, but discomfort reported when palpating the quadriceps muscles suggests a possible muscular issue. The palpable femoral and peripheral pulses indicate normal peripheral circulation.
Given the indoor status of the cat and the absence of typical risk factors for certain diseases, your focus on less common causes such as toxoplasma, cryptococcus, and FIP is appropriate. Running CK and AST for myositis markers, as well as performing radiographs of the chest and ultrasound of the abdomen, are sensible next steps to further investigate potential causes.
Your plan to sample the anterior chamber of the affected eye for cytology and rtPCR for FIP is a brilliant suggestion. However, we were not brave enough to proceed with this step at this time. Similarly, we did not perform serum protein electrophoresis due to increased globulins, but this was also a great suggestion. These tests could provide valuable insights into the underlying cause of the cat’s condition.
Initiating treatment for dehydration and providing nutritional support are crucial steps to stabilize the cat’s condition. Continued monitoring and further diagnostic tests will be essential to confirm a definitive diagnosis and guide appropriate treatment. Great job!
These were the results of the investigations we performed:
Creatine Kinase: Elevated at 1020 U/l (Reference interval 50 β 200 U/l).
Urine protein-to-creatinine ratio (UPCR): Non-proteinuric with a value of 0.1 (Reference ranges: Non-proteinuric: 0.0 β 0.2, Borderline proteinuric: 0.2 β 0.5, Proteinuric: > 0.5).
Urine culture: No growth.
FIV/FeLV ELISA: Both negative.
Blood pressure: Systolic blood pressure of 130 mmHg (measured by Doppler).
Total thyroxine: Total T4 levels within normal range at 30 nmol/L (Reference range: 10 – 60 nmol/l or 2.3 Β΅g/dl Reference range: 0.8 β 4.7 Β΅g/dl).
Coagulation profile: Within normal limits with PT of 12 sec (Reference range: 8.0-15.0 sec), aPTT of 18 sec (Reference range: 9.0-20.0 sec), and D-Dimers of 0.08 mg/L (Reference range: 0-0.56 mg/L).
Toxoplasma serology (Immunofluorescence): IgG positive at 1/512 (Reference range: < 1/32), IgM negative (Reference range: < 1/16). Feline Coronavirus serology: Negative. Thoracic point of care ultrasound (TPOCUS): Presence of free fluid in the pleural space, no B lines evident, left atrium-to-aorta ratio of 1.4. Echocardiography: Unremarkable, no evidence of structural heart disease. Abdominal ultrasound: No free abdominal fluid, unremarkable findings. Thoracic radiography: Identified pleural effusion, unable to evaluate heart and lungs due to the effusion. Thoracic radiography (after thoracocentesis): Revealed a 3cm x 2cm soft tissue mass lesion in the left caudal lung. CT: Thorax, abdomen including hindlimbs: Identified a mass lesion in the left lung lobe, no abdominal abnormalities, and mass lesions in the hind limb musculature. Hindlimb radiography: Showed bilateral soft tissue swelling of the quadriceps muscle. Hindlimb ultrasound: Identified bilateral mass lesions with small fluid pockets in the quadriceps muscle, Doppler examination showed no abnormalities. Pleural fluid analysis: Revealed modified transudate. FNA lung mass: Cytology consistent with epithelial neoplasia with features of malignancy (carcinoma, highly likely) and suppurative inflammation. FNA hind limb masses: Cytology consistent with epithelial neoplasia with features of malignancy (carcinoma, highly likely) and suppurative inflammation. Intraocular pressure: Normal. Thank you again for your brilliant reply! Scott π
Replying to Kirsty McInarlin 05/05/2024 - 20:29
Hi Kirsty!
Welcome to the course! It’s great to have you join us. It sounds like you’re doing amazing work at PDSA, despite the challenges you face. Respiratory cases can indeed be daunting, but I’m sure you’ll gain valuable insights and tips to help narrow down differentials.
I wanted to share that my first job after graduation was also at the PDSA in Glasgow, and I absolutely loved working there. I’m glad to hear you’re excited about your first course with VTX! We aim to provide quality CPD in a flexible format to accommodate busy schedules like yours. If you have any questions or need assistance during the course, feel free to reach out. Enjoy the learning experience!
Scott π
Replying to Nichola Healey 03/05/2024 - 20:54
Hi Nichola! Welcome to the course! It’s great to hear about your background and your commitment to keeping up with industry knowledge. We’re glad to have you here and hope you find the topics and speakers engaging and informative. If you have any questions or need any assistance along the way, feel free to reach out. Enjoy the course and getting stuck into the material!
I’m curious, since you’re still working within the industry, could you share which part you’re currently involved in? It’s always fascinating to hear about the different paths people take after their clinical work.
Scott π
Replying to Nikki McLeod 08/05/2024 - 13:16
Here is the link!
Let us know if you struggle to acess!
Scott π
Replying to Rodolfo L. 06/05/2024 - 07:59
Hi Rodolfo,
Thank you for the warm welcome! I’m excited that you’re part of the course too and I’m looking forward to learning from you.
Best wishes,
Scott π
Replying to MΓ³nica P. 06/05/2024 - 14:17
Hi MΓ³nica,
Thank you for your update. It sounds challenging to manage everything without specialists nearby. It’s good that you’re exploring options to send the blood overseas for testing. It’s also reassuring that the owner is compliant with the medication regimen.
I’m sorry to hear about the limitations with the fT4 testing. Please do send me the results to my email, and we can discuss them further. In the meantime, a proper check-up sounds like a great next step. The in-house IDEXX total T4 measurement should be accurate. Let me know if there’s anything else I can assist with.
Best regards,
Scott π
Replying to Laura S. 06/05/2024 - 16:09
Hello Laura!
Thank you so much for joining us, we really appreciate the support!
Welcome back to practice after your maternity leave! The veterinary medicine is the easy part of life with kids around! π
Let me know if you have any questions.
Scott π
Replying to Laura S. 07/05/2024 - 10:43
Hey Laura.
I hope you are well! Thank you for your BRILLAINT question!
I will let Liz start the answer for this one. I hope you are enjoying the course.
Scott π
-
AuthorPosts